We are live on ! Find out more
FLGT icon

Fulgent Genetics

37 hedge funds and large institutions have $35.5M invested in Fulgent Genetics in 2016 Q4 according to their latest regulatory filings, with 25 funds opening new positions, 4 increasing their positions, 3 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

733% more first-time investments, than exits

New positions opened: 25 | Existing positions closed: 3

147% more funds holding

Funds holding: 1537 (+22)

45% more capital invested

Capital invested by funds: $24.4M → $35.5M (+$11.1M)

33% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 3

17.35% more ownership

Funds ownership: 0%17.35% (+17%)

Holders
37
Holders Change
+22
Holders Change %
+146.67%
% of All Funds
0.92%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
25
Increased
4
Reduced
3
Closed
3
Calls
Puts
Net Calls
Net Calls Change

FLGT Hedge Fund Activity: Q4 2016 in Review

37 of the 4,001 institutional investors tracked by Wall St. Rank reported a position in Fulgent Genetics (FLGT) for Q4 2016, worth a combined $35.5M — up 45% from $24.4M a quarter earlier.

Buyers outnumbered sellers: 25 funds opened new FLGT positions and 3 closed out — a net gain of 22 holders — while 4 added to existing stakes and 3 trimmed.

The largest buyer was Vanguard Group, opening a new position worth an estimated $2.15M. The largest seller was Point72 Asset Management, exiting entirely with an estimated $738K sold.

  • 37 institutional investors held Fulgent Genetics (FLGT) as of Q4 2016, up from 15 in Q3 2016.
  • Funds reported $35.5M of Fulgent Genetics stock for Q4 2016, up 45% quarter-over-quarter.
  • 25 funds opened new Fulgent Genetics positions in Q4 2016 and 3 closed out, a net change of +22 holders.
  • The largest Fulgent Genetics buyer in Q4 2016 was Vanguard Group, an estimated $2.15M added.
  • The largest Fulgent Genetics seller in Q4 2016 was Point72 Asset Management, an estimated $738K sold.

Based on aggregated 13F filings for Q4 2016.